Ferring Forges Fertility Pact With Chinese Academy of Sciences
Executive Summary
The Swiss firm's chief scientific officer tells Scrip that working with world-renowned researchers in Beijing can only help Ferring achieve its goal of becoming the number one reproductive medicines company.
You may also be interested in...
Ferring Plots Genomics Path With Celmatix Pact
The firms have inked a collaboration which aims to explore individual differences in women’s responses to IVF treatment, improve success rates and reduce side effects such as ovarian hyper-stimulation syndrome.
Pharma Firms Welcome 'Pragmatic' EU Reforms But Concerns Persist
The European parliament has voted for legislation it says will lead to fairer, more accessible healthcare. The continent's drugmakers are still not wholly convinced.
Sector Stalwart Appalled At Lack Of UK Investor Interest In Biotech
Ali Mortazavi, CEO of e-therapeutics, says the RNAi specialist is delisting from AIM and describes the UK markets as “completely broken and closed” to biotech firms.